Gli1 reduces drug sensitivity by regulating cell cycle through pi3k/akt/gsk3/cdk pathway in acute myeloid leukemia

HIGHLIGHTS

• who: Cheng Zhou from the Liquid bone marrow samples were collected from three AML-RR patients who were diagnosed with AML according to , WHO criteria and treated at Xiangya Hospital of Central South University, Hunan, ChinaFor comparison, three healthy volunteer donors were included as controls. The experimental protocols were approved by the ethical committee of Xiangya Hospital, Central South University. Informed consent was obtained from all research subjects. Cell culture have published the paper: GLI1 reduces drug sensitivity by regulating cell cycle through PI3K/AKT/GSK3/CDK pathway in acute myeloid leukemia, in the Journal: (JOURNAL)
 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.